Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]
Tony Hogben is the Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS). Pfizer Digital Omnichannel Services & Solutions (OSS) is at the forefront of transforming how [...]
Amazon's new Bio Discovery tool can design and run experiments for antibody research and drug synthesis. [...]
Cardiff-based Antiverse, a biotechnology company developing AI-powered therapeutic antibody discovery tools, has closed a $9.3 million Series A financing to expand its computational platform and advan [...]
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
When Anthropic quietly released Claude Design in April as a "research preview," it generated the kind of instant traction most product teams dream about: more than one million users in its f [...]
Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]
With web publishers in crisis, a new open standard lets them set the ground rules for AI scrapers. (Or, at least it will try.) The new Really Simple Licensing (RSL) standard creates terms that partici [...]
Paramount Skydance CEO David Ellison is apparently still hopeful that investors will approve his $108.4 billion hostile takeover of Warner Bros. Discovery. Paramount Skydance announced Thursday that i [...]